Works matching IS 17562872 AND DT 2018 AND VI 10 AND IP 3
Results: 3
Cabozantinib in the treatment of advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy: clinical trial evidence and experience.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 3, p. 109, doi. 10.1177/1756287217748867
- By:
- Publication type:
- Article
The impact of comorbidities, sex and age on the occurrence of acute kidney injury among patients undergoing nephron-sparing surgery.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 3, p. 103, doi. 10.1177/1756287217747190
- By:
- Publication type:
- Article
Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections.
- Published in:
- Therapeutic Advances in Urology, 2018, v. 10, n. 3, p. 95, doi. 10.1177/1756287217745772
- By:
- Publication type:
- Article